ALNYLAM PHARMACEUTICALS, INC.

Connections Alnylam Pharmaceuticals, Inc.

Stocks

ALNY

US02043Q1076

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:37:03 2026-06-10 am EDT			5-day change	1st Jan Change
296.52 ^USD	-0.39%		+1.37%	-25.42%

08:10am	Alnylam, Genesis Pharma Expand Commercial Partnership Into 4 Nordic Markets	MT
Jun. 09	Alnylam Pharmaceuticals, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 11:20 AM

46

Listed companies

22

Private companies

149

Insiders

Relation chart of related listed companies: Alnylam Pharmaceuticals, Inc.

Active Relations

Past Relations

Related listed companies: Alnylam Pharmaceuticals, Inc.

BIOCRYST PHARMACEUTICALS, INC.

MYRIAD GENETICS, INC.

ULTRAGENYX PHARMACEUTICAL INC.

RHYTHM PHARMACEUTICALS, INC.

Stuart Arbuckle

ATEA PHARMACEUTICALS, INC.

Keith Pietropaolo

SPYRE THERAPEUTICS, INC.

Joshua Friedman

SQZ BIOTECHNOLOGIES COMPANY

OVID THERAPEUTICS INC.

Kevin Fitzgerald

TAKEDA PHARMACEUTICAL COMPANY LIMITED

John Maraganore

ELEVANCE HEALTH, INC.

Dennis Ausiello

BLACKSTONE INC.

John Maraganore

KARYOPHARM THERAPEUTICS INC.

EGETIS THERAPEUTICS AB

Margarida Duarte

SERES THERAPEUTICS, INC.

Dennis Ausiello

PROQR THERAPEUTICS N.V.

INTELLIA THERAPEUTICS, INC.

Marika St Amand

Olivier Brandicourt

Olivier Brandicourt

PLIANT THERAPEUTICS, INC.

PRAXIS PRECISION MEDICINES, INC.

Stuart Arbuckle

VIR BIOTECHNOLOGY, INC.

CAMP4 THERAPEUTICS CORPORATION

Satya Kuchimanchi

KYMERA THERAPEUTICS, INC.

John Maraganore

SCHOLAR ROCK HOLDING CORPORATION

Akshay Vaishnaw

AUTOLUS THERAPEUTICS PLC

BEAM THERAPEUTICS INC.

John Maraganore

DYNE THERAPEUTICS, INC.

TRANSMEDICS GROUP, INC.

Gerardo Hernandez

TARSUS PHARMACEUTICALS, INC.

TAYSHA GENE THERAPIES, INC.

Laura Sepp-Lorenzino

SIONNA THERAPEUTICS, INC.

LEXEO THERAPEUTICS, INC.

Laura Sepp-Lorenzino

GENERATE BIOMEDICINES, INC.

CENTESSA PHARMACEUTICALS PLC

METAGENOMI THERAPEUTICS, INC.

RANI THERAPEUTICS HOLDINGS, INC.

Dennis Ausiello

UPSTREAM BIO, INC.

RAPPORT THERAPEUTICS, INC.

John Maraganore

FORTREA HOLDINGS INC.

Agnieszka Gallagher

Jeffrey Poulton

DIANTHUS THERAPEUTICS, INC.

HEMAB THERAPEUTICS HOLDINGS, INC.

John Maraganore

Akshay Vaishnaw

Catherine Madigan

Active Relations

Past Relations

Relationship chart for related private companies: Alnylam Pharmaceuticals, Inc.

Active Relations

Past Relations

Related private companies: Alnylam Pharmaceuticals, Inc.

ARCH Venture Partners LLC

Investment Managers

John Maraganore

Biotechnology Innovation Organization

Miscellaneous Commercial Services

John Maraganore

Yvonne Greenstreet

Stuart Arbuckle

KinDex Pharmaceuticals, Inc.

Biotechnology

Dennis Ausiello

CHP Management, Inc.

Investment Managers

Atlas Venture Advisors, Inc.

Investment Managers

John Maraganore

Akshay Vaishnaw

Massachusetts Institute of Technology

Finance/Rental/Leasing

The Royal Society

Investment Trusts/Mutual Funds

Carolyn Bertozzi

National Academy of Sciences

Miscellaneous Commercial Services

Benjamin Cravatt

Dennis Ausiello

Carolyn Bertozzi

American Academy of Arts & Sciences

Miscellaneous Commercial Services

Benjamin Cravatt

Dennis Ausiello

Carolyn Bertozzi

National Academy of Medicine (United States)

Miscellaneous Commercial Services

Benjamin Cravatt

Dennis Ausiello

Carolyn Bertozzi

American Philosophical Society

Miscellaneous Commercial Services

Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Margaret Hamburg

BIOTECanada

Biotechnology

Oligonucleotide Therapeutics Society, Inc.

Miscellaneous Commercial Services

Laura Sepp-Lorenzino

Harvard Medical School

Other Consumer Services

Dennis Ausiello

Yvonne Greenstreet

Longwood Fund Management LLC

Investment Managers

John Maraganore

Christoph Westphal

Atlas Venture Life Science Advisors LLC

Investment Managers

Alnylam UK Ltd.

Biotechnology

Jeffrey Poulton

National Academy of Inventors

Miscellaneous Commercial Services

Benjamin Cravatt

Carolyn Bertozzi

Dewpoint Therapeutics, Inc.

Biotechnology

Olivier Brandicourt

Hemab ApS

Biotechnology

John Maraganore

Akshay Vaishnaw

Nucleate Bio, Inc.

John Maraganore

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Biotechnology	28
Pharmaceuticals: Major	17
Miscellaneous Commercial Services	10
Investment Managers	6
Medical Specialties	2
Other Consumer Services	1
Investment Trusts/Mutual Funds	1
Managed Health Care	1
Finance/Rental/Leasing	1

Countries of related companies

United States	56
United Kingdom	4
Netherlands	2
Switzerland	2
Denmark	1
Canada	1
Sweden	1
Japan	1

Company Profile

Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR) in adults ; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Companyâ€™s clinical development programs include Cemdisiran, Zilebesiran, Elebsiran, Mivelsiran, ALN-6400, and ALN-HTT02. It is developing Cemdisiran to treat complement-mediated diseases.

Employees

2,500

Sector

Pharmaceuticals

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!